Passive Transfer of Animal-Derived Polyclonal Hyperimmune Antibodies Provides Protection of Mice from Lethal Lassa Virus Infection
Background: Lassa virus (LASV) can cause severe acute systemic infection in humans. No approved antiviral drugs or vaccines are currently available. Antibody-based therapeutics are considered a promising treatment strategy in the management of LASV disease. Methods: We used chimeric Ifnar<sup>−/−</s...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI AG
2023-06-01
|
| Col·lecció: | Viruses |
| Matèries: | |
| Accés en línia: | https://www.mdpi.com/1999-4915/15/7/1436 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|